FIG 1.
Plasma concentration-time profile of prothionamide (PTO) after dose administration. Gray and red lines represent individual profile and median, respectively. One patient who was administered 500 mg of PTO was excluded.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.